BLES Biochemicals Inc., the market leader for pulmonary surfactant in Canada, manufactures and distributes BLES® (bovine lipid extract surfactant). BLES® is a pulmonary surfactant for use in the treatment of premature infants suffering from Neonatal Respiratory Distress Syndrome. BLES® is unique; there is no generic form of this product. BLES Biochemicals Inc. is a privately-owned Canadian-controlled pharmaceutical company.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.